Downes J, Andrew J H
Department of Microbiology, St Vincent's Hospital, Melbourne.
Pathology. 1988 Jul;20(3):260-3. doi: 10.3109/00313028809059504.
The minimal inhibitory concentrations (MICs) of the newer beta-lactam antibiotic, imipenem, were compared with those of cefoxitin, cefotetan, penicillin, amoxycillin, ticarcillin and metronidazole against 114 clinical isolates of the Bacteroides fragilis group of anaerobic organisms. The ability of clavulanic acid, a beta-lactamase inhibitor, to potentiate the in vitro activity of amoxycillin and ticarcillin was also studied. Using an agar dilution technique we found imipenem to be the most active beta-lactam antibiotic tested having an MIC50 of 0.25 microgram/ml and inhibiting all isolates at a concentration of 4 micrograms/ml. Metronidazole had comparable activity with a MIC50 of 0.5 microgram/ml and all isolates inhibited by 1 microgram/ml. Cefoxitin and cefotetan showed similar activity both with a MIC50 of 8 micrograms/ml against the B. fragilis group, while penicillin, amoxycillin and ticarcillin all had a MIC50 of 16 micrograms/ml. Clavulanic acid significantly reduced the MIC50 of amoxycillin and ticarcillin to 0.5 micrograms/ml and 0.25 micrograms/ml, respectively.
将新型β-内酰胺抗生素亚胺培南的最低抑菌浓度(MIC)与头孢西丁、头孢替坦、青霉素、阿莫西林、替卡西林和甲硝唑针对114株脆弱拟杆菌属厌氧生物临床分离株的最低抑菌浓度进行了比较。还研究了β-内酰胺酶抑制剂克拉维酸增强阿莫西林和替卡西林体外活性的能力。使用琼脂稀释技术,我们发现亚胺培南是所测试的活性最强的β-内酰胺抗生素,其MIC50为0.25微克/毫升,在浓度为4微克/毫升时可抑制所有分离株。甲硝唑具有相当的活性,MIC50为0.5微克/毫升,在1微克/毫升时可抑制所有分离株。头孢西丁和头孢替坦表现出相似的活性,针对脆弱拟杆菌属的MIC50均为8微克/毫升,而青霉素、阿莫西林和替卡西林的MIC50均为16微克/毫升。克拉维酸分别将阿莫西林和替卡西林的MIC50显著降低至0.5微克/毫升和0.25微克/毫升。